{"id":"placebo-for-theophylline","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL190","moleculeType":"Protein","molecularWeight":"180.17"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to measure the effect of patient expectation and the natural disease course independent of active drug treatment. In this case, it serves as a control comparator in studies evaluating theophylline efficacy. Any observed benefit reflects placebo response, regression to the mean, or natural disease resolution rather than pharmacological activity.","oneSentence":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation rather than direct drug action.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:03.549Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in theophylline clinical trials"}]},"trialDetails":[{"nctId":"NCT04551170","phase":"PHASE2","title":"Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2020-07-13","conditions":"Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a","enrollment":34},{"nctId":"NCT03029429","phase":"PHASE2","title":"Theophylline Treatment for Pseudohypoparathyroidism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2018-09-01","conditions":"Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy","enrollment":29},{"nctId":"NCT03984188","phase":"PHASE3","title":"Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD","status":"COMPLETED","sponsor":"University of Miami","startDate":"2021-02-23","conditions":"COPD, COPD Exacerbation, COPD Exacerbation Acute","enrollment":100},{"nctId":"NCT06272916","phase":"","title":"Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-03","conditions":"Post-Dural Puncture Headache","enrollment":630},{"nctId":"NCT04789499","phase":"PHASE2","title":"Smell in Covid-19 and Efficacy of Nasal Theophylline","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-03-15","conditions":"Covid19, Anosmia, Olfactory Disorder","enrollment":51},{"nctId":"NCT03897335","phase":"PHASE3","title":"Preventing Acute Kidney Injury (AKI) in Pediatric Patients","status":"UNKNOWN","sponsor":"Le Bonheur Children's Hospital","startDate":"2019-02-07","conditions":"Acute Kidney Injury","enrollment":80},{"nctId":"NCT03990766","phase":"PHASE2","title":"Smell Changes & Efficacy of Nasal Theophylline","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-05-15","conditions":"Olfactory Disorder, Anosmia, Viral Infection","enrollment":27},{"nctId":"NCT04309877","phase":"EARLY_PHASE1","title":"Theophylline for Depression Study","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2023-03","conditions":"Depression","enrollment":""},{"nctId":"NCT02261727","phase":"PHASE4","title":"Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study","status":"COMPLETED","sponsor":"The George Institute","startDate":"2014-06","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":1670},{"nctId":"NCT00003684","phase":"PHASE3","title":"Theophylline in Treating Cancer Patients With Shortness of Breath","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"1998-03-24","conditions":"Pulmonary Complications, Quality of Life, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":3},{"nctId":"NCT04065035","phase":"NA","title":"A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming","status":"COMPLETED","sponsor":"Revision Skincare","startDate":"2018-12-13","conditions":"Photodamaged Skin, Skin Care","enrollment":46},{"nctId":"NCT01759862","phase":"NA","title":"Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-11","conditions":"Function of Renal Transplant","enrollment":50},{"nctId":"NCT01696214","phase":"PHASE4","title":"A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2012-10","conditions":"Asthma","enrollment":20},{"nctId":"NCT01599871","phase":"PHASE3","title":"Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Hospital Son Espases","startDate":"2011-01","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":70},{"nctId":"NCT00299858","phase":"PHASE2, PHASE3","title":"Theophylline in Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2006-10","conditions":"COPD","enrollment":24},{"nctId":"NCT01875003","phase":"PHASE3","title":"A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2013-08-31","conditions":"Asthma","enrollment":348},{"nctId":"NCT01902758","phase":"PHASE2, PHASE3","title":"Drug Combination on Exercise Performance at High Altitude","status":"COMPLETED","sponsor":"University of Montana","startDate":"2013-08","conditions":"Acute Mountain Sickness","enrollment":28},{"nctId":"NCT01684683","phase":"PHASE4","title":"The Effect of Theophylline in the Treatment of Bronchiectasis","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2012-11","conditions":"Bronchiectasis","enrollment":100},{"nctId":"NCT01769898","phase":"PHASE4","title":"The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2013-07","conditions":"Bronchiectasis","enrollment":50},{"nctId":"NCT01125748","phase":"PHASE4","title":"A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2010-05","conditions":"Allergic Asthma","enrollment":176},{"nctId":"NCT02088502","phase":"PHASE2, PHASE3","title":"Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy","status":"UNKNOWN","sponsor":"Isfahan University of Medical Sciences","startDate":"2013-09","conditions":"Contrast-Induced Nephropathy","enrollment":96},{"nctId":"NCT00893009","phase":"NA","title":"The Effect on Small Airways of Addition of Theophylline as Inducer of Histone Deacilase Activity for Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Treated With Inhaled Steroids and Long Acting Beta Agonists","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2009-07","conditions":"COPD","enrollment":30},{"nctId":"NCT00791960","phase":"NA","title":"Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2008-11","conditions":"Nausea, Vomiting","enrollment":149},{"nctId":"NCT00634413","phase":"PHASE2","title":"Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD","status":"COMPLETED","sponsor":"Pulmagen Therapeutics","startDate":"2008-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":91}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":738,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Theophylline placebo 1 tab twice daily"],"phase":"marketed","status":"active","brandName":"Placebo (for Theophylline)","genericName":"Placebo (for Theophylline)","companyName":"The George Institute","companyId":"the-george-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and physiological expectation rather than direct drug action. Used for Control arm in theophylline clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}